Research output per year
Research output per year
Fingerprint
Dive into the research topics where Daruka Mahadevan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Safety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced/metastatic epithelial cancer: A phase i clinical trial (SPICE)
Fakih, M., Harb, W., Mahadevan, D., Babiker, H., Berlin, J., Lillie, T., Krige, D., Carter, J., Cox, C., Patel, M., Parfitt, L., Powell, M. & Rosen, L., Apr 24 2023, In: Journal for ImmunoTherapy of Cancer. 11, 4, e006561.Research output: Contribution to journal › Article › peer-review
Open Access -
A multicenter phase 1/2 study investigating the safety, pharmacokinetics, pharmacodynamics and efficacy of a small molecule antimetabolite, RX-3117, plus nab-paclitaxel in pancreatic adenocarcinoma
Babiker, H., Schlegel, P. J., Hicks, L. G., Bullock, A. J., Burhani, N., Mahadevan, D., Elquza, E., Borad, M. J., Benaim, E., Peterson, C., Heaton, C. & Ocean, A. J., Feb 2022, In: Investigational New Drugs. 40, 1, p. 81-90 10 p.Research output: Contribution to journal › Article › peer-review
-
Clinical trials targeting neurofibromatoses-associated tumors: a systematic review
Souza, G. R., Abdalla, A. & Mahadevan, D., Jan 1 2022, In: Neuro-Oncology Advances. 4, 1, vdac005.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Pembrolizumab Achieves a Complete Response in an NF-1 Mutated, PD-L1 Positive Malignant Peripheral Nerve Sheath Tumor: A Case Report and Review of the Benchmarks
Larson, K., Russ, A., Arif-Tiwari, H., Mahadevan, D., Elliott, A., Bhattacharyya, A. & Babiker, H., May 1 2022, In: Journal of Immunotherapy. 45, 4, p. 222-226 5 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study
Gregory, G. P., Kumar, S., Wang, D., Mahadevan, D., Walker, P., Wagner-Johnston, N., Escobar, C., Bannerji, R., Bhutani, D., Chang, J., Hernandez-Ilizaliturri, F. J., Klein, A., Pagel, J. M., Rybka, W., Yee, A. J., Mohrbacher, A., Huang, M., Farooqui, M., Marinello, P. & Quach, H., Feb 22 2022, In: Blood Advances. 6, 4, p. 1232-1242 11 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations